SUMMARY: Tural-Kara T, Özdemir H, İnce E, İleri T, Çiftçi E. Fonsecaea pedrosoi: A rare cause of dental infection and maxillary osteomyelitis in a child with acute lymphoblastic leukemia. Turk J Pediatr 2016; 58: 679-682.Dental lesions are commonly seen in children with malignancy. We report a child with acute lymphoblastic leukemia who had black-brown dental lesion during the febrile neutropenic episode. Histopathological examination of dental lesion showed fungal hyphae and conidia. F. pedrosoi that was isolated from the tissue culture. The patient was treated with intravenous liposomal amphotericin B therapy for 5 weeks and he was discharged on oral voriconazole. On follow-up, clinical symptoms recovered. Although F. pedrosoi may be an unusual causative agent of dental infection and maxillary osteomyelitis, it should be considered in patient with black-brown lesions which do not respond to antibacterial treatment.
Key words: acute lymphoblastic leukemia, children, dental infection, Fonsecaea pedrosoi, osteomyelitis.Patients with acute myeloid leukemia, relapsed leukemia, those receiving highly myelosuppressive chemotherapy and allogeneic hematopoietic stem cell transplant recipients have high risk for fungal infections. Even though invasive fungal infection related mortality can be reduced with prophylactic antifungal therapy, it still continues to be a major cause of morbidity and mortality in neutropenic patients 1 . The incidence of fungal infections in acute lymphoblastic leukemia (ALL) is reportedly 24% and it can increase with prolonged duration of neutropenia 2 .
C h r o m o b l a s t o m y c o s i s p e r s e , i s a n infection of skin and subcutaneous tissue 3 .Chromoblastomycosis is a well-established disease caused by F. pedrosoi and have just a few case reports. However, F. pedrosoi associated dental infections and maxillary osteomyelitis have not been reported. To our knowledge, this is the first reported pediatric case of dental infection and maxillary osteomyelitis caused by F. pedrosoi.
Case ReportA 6-year-old boy with a diagnosis of standard risk B precursor ALL presented with fever on the 43 rd day of delayed intensification therapy as per COG AALL0331 chemotherapy regimen. On physical examination, he was febrile and pale. His vital signs included a temperature of 39 ºC, heart rate of 128 beats per minute, respiratory rate of 32 breaths per minute, and a blood pressure of 86/52 mmHg. He had 3 cm hepatomegaly below the right costal margin and 2 cm splenomegaly below the left costal margin. The rest of physical examination was normal, and no infectious focus was detected. Patient's laboratory test results were as followed; hemoglobin 11.7 g/dl, white blood cell count 0.2x10 3 /mm 3 , absolute neutrophil count 0/mm 3 (neutrophils 0%, lymphocytes 90%, monocytes 4% and eosinophils 6%), platelet count 16x10 3 /mm 3 , C-reactive protein 62 mg/L. He was started on intravenous cefoperazone-sulbactam for fever and neutropenia. The following day, intravenous teicoplanin and acyclovir were